Business
Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er … hedge fund manager Bill...
Hi, what are you looking for?
Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er … hedge fund manager Bill...
– Allergan’s newest strategy to fend off a $51 billion hostile takeover bid from Valeant Pharmaceuticals involves filing a suit in a California...
– Dr. Oren Tessler, Assistant Professor of Clinical Surgery at LSU Health Sciences Center New Orleans School of Medicine, is part of a team...
– If a meeting is called, Ackman and Pearson would be expected to try to utilize it to vote in a new slate of directors. –...
– Lawyers for Allergan, Valeant Pharmaceuticals and Pershing Square yesterday announced they had mutually agreed to a common understanding, without waiting for a...
– – Fighting a hostile takeover battle, in a case where increasingly support seems to be evenly divided amongst the bidding and defending...
– – Last week pharmaceuticals company Allergan Inc, the Irvine California based maker of Botox received a second, increased, takeover offer from Quebec...
– – If at first you don’t succeed, try, try again. Just three days ago Quebec based pharmaceuticals company Valeant, led by its aggressive...
– – The Quebec based drug maker Valeant, led by its CEO Mike Pearson, has been on the acquisition trail again a lot lately,...
– – Three weeks ago Quebec based pharmaceuticals company Valeant made a US$47 billion hostile takeover bid, in cash and stock, to acquire Irvine...